Literature DB >> 17002565

On genetic studies of bone loss.

Fang Yang1, Hui Shen, Hui Jiang, Hong-Wen Deng.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 17002565      PMCID: PMC1839053          DOI: 10.1359/jbmr.060807

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  23 in total

1.  Characterization of perimenopausal bone loss: a prospective study.

Authors:  R Recker; J Lappe; K Davies; R Heaney
Journal:  J Bone Miner Res       Date:  2000-10       Impact factor: 6.741

2.  Natural history of bone loss over 6 years among premenopausal and early postmenopausal women.

Authors:  K E Bainbridge; M F Sowers; M Crutchfield; X Lin; M Jannausch; S D Harlow
Journal:  Am J Epidemiol       Date:  2002-09-01       Impact factor: 4.897

3.  Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.

Authors:  T Salmén; A M Heikkinen; A Mahonen; H Kröger; M Komulainen; S Saarikoski; R Honkanen; P H Mäenpää
Journal:  J Bone Miner Res       Date:  2000-02       Impact factor: 6.741

4.  Comparison of cross-sectional and longitudinal measurements of age-related changes in bone mineral content.

Authors:  J W Davis; P D Ross; R D Wasnich; C J Maclean; J M Vogel
Journal:  J Bone Miner Res       Date:  1989-06       Impact factor: 6.741

5.  Heritability of bone mass: a longitudinal study in aging male twins.

Authors:  J C Christian; P L Yu; C W Slemenda; C C Johnston
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

6.  Determinants of the rate of bone loss in normal postmenopausal women.

Authors:  I R Reid; R W Ames; M C Evans; S J Sharpe; G D Gamble
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

7.  Quantitative genetic analysis of circulating levels of biochemical markers of bone formation.

Authors:  G Livshits; C Yakovenko; E Kobyliansky
Journal:  Am J Med Genet       Date:  2000-10-02

8.  Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men.

Authors:  Sundeep Khosla; B Lawrence Riggs; Elizabeth J Atkinson; Ann L Oberg; Carmelo Mavilia; Francesca Del Monte; L Joseph Melton; Maria Luisa Brandi
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

9.  Age, gender, and body mass effects on quantitative trait loci for bone mineral density: the Framingham Study.

Authors:  D Karasik; L A Cupples; M T Hannan; D P Kiel
Journal:  Bone       Date:  2003-09       Impact factor: 4.398

Review 10.  Genetics of osteoporosis.

Authors:  Munro Peacock; Charles H Turner; Michael J Econs; Tatiana Foroud
Journal:  Endocr Rev       Date:  2002-06       Impact factor: 19.871

View more
  5 in total

1.  Comparison of whole genome linkage scans in premenopausal and postmenopausal women: no bone-loss-specific QTLs were implicated.

Authors:  H Yan; Y-J Liu; Q Zhou; P Xiao; R R Recker; H-W Deng
Journal:  Osteoporos Int       Date:  2008-09-03       Impact factor: 4.507

2.  UGT2B17 gene deletion associated with an increase in bone mineral density similar to the effect of hormone replacement in postmenopausal women.

Authors:  S Giroux; J Bussières; A Bureau; F Rousseau
Journal:  Osteoporos Int       Date:  2011-05-26       Impact factor: 4.507

3.  Genetic influences on bone loss in the San Antonio Family Osteoporosis study.

Authors:  J R Shaffer; C M Kammerer; J M Bruder; S A Cole; T D Dyer; L Almasy; J W MacCluer; J Blangero; R L Bauer; B D Mitchell
Journal:  Osteoporos Int       Date:  2008-04-15       Impact factor: 4.507

4.  The osteoporosis revolution marches on.

Authors:  Lawrence G Raisz
Journal:  J Orthop Sci       Date:  2007-08-02       Impact factor: 1.601

5.  Network Analysis Implicates Alpha-Synuclein (Snca) in the Regulation of Ovariectomy-Induced Bone Loss.

Authors:  Gina Calabrese; Larry D Mesner; Patricia L Foley; Clifford J Rosen; Charles R Farber
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.